
Abbott Laboratories ABT
€ 88.82
0.2%
Geschäftsbericht 2025
hinzugefügt 20.02.2026
Abbott Laboratories Betriebsaufwand 2011-2026 | ABT
Betriebsaufwand Jährlich Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 14.1 B | 14.2 B | 13.3 B | 8.64 B | 8.79 B | 8.43 B | 9.18 B | 16.4 B | 16.9 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.9 B | 8.43 B | 12.2 B |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.42 | -2.43 % | $ 128 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.96 | -0.95 % | $ 1.62 B | ||
|
FONAR Corporation
FONR
|
28.7 M | $ 18.59 | -0.08 % | $ 122 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.14 | -2.56 % | $ 259 M | ||
|
Globus Medical
GMED
|
547 M | $ 90.44 | 2.08 % | $ 12.2 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 36.34 | -1.09 % | $ 5.42 K | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.79 | -5.79 % | $ 1.09 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.29 | -0.21 % | $ 715 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 54.5 | 0.66 % | $ 1.6 B | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.0 | 0.34 % | $ 16.9 M | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 85.22 | -0.48 % | $ 2.96 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.7 | -1.54 % | $ 368 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.83 | -1.1 % | $ 69.7 M | ||
|
Medtronic PLC
MDT
|
15.3 B | $ 86.5 | 0.25 % | $ 111 B | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.67 | -5.3 % | $ 28 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
2.19 B | $ 167.2 | -2.72 % | $ 12.5 B | ||
|
Orthofix Medical
OFIX
|
344 M | $ 11.72 | -0.4 % | $ 464 M | ||
|
AxoGen
AXGN
|
121 M | $ 30.54 | -6.43 % | $ 1.41 B | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Insulet Corporation
PODD
|
531 M | $ 204.83 | 0.65 % | $ 14.4 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.63 | 3.95 % | $ 7.29 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.0 | -3.27 % | $ 847 M | ||
|
Smith & Nephew plc
SNN
|
2.67 B | $ 31.7 | -2.85 % | $ 23.8 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 331.21 | -0.33 % | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
221 M | $ 24.24 | -1.38 % | $ 554 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.6 | 1.68 % | $ 37.3 M | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.68 | 7.69 % | $ 31.9 M | ||
|
TransMedics Group
TMDX
|
254 M | $ 107.12 | 2.21 % | $ 3.64 B | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 18.93 | -1.28 % | $ 1.29 B | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 9.66 | -0.41 % | $ 346 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 61.25 | -2.14 % | $ 90.7 B | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 11.14 | 1.55 % | $ 1.67 B |